Work

Proscillaridin A inhibits lung cancer cell growth and motility through downregulation of the EGFR-Src-associated pathway.

Year: 2023

Type: article

Abstract: and the risk score of the gene signature based on these two factors were negatively correlated with overall survival and could be used as independent prognostic factors. In conclusion, we speculate that proscillaridin A inhibits lung cancer cell growth and motility by regulating EGFR-Src-associated pathways.

Source: PubMed Central

Authors: Jeng-Yuan Tsai, Chia-Wei Weng, Yi-Hua Lai, Meng-Fang Tsai, Hsuan-Yu Chen, Jeremy Jw Chen

Institutions: National Chung Hsing University, Chung Shan Medical University, China Medical University, China Medical University Hospital, Dayeh University, Institute of Statistical Science, Academia Sinica, Academia Sinica

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Science and Technology Council

OpenAlex ID: W4389452910

FWCI: 0.17

Cites: 68

Cited by: 1

Related to: 10